Point - Legitimate and illegitimate tests of free-analyte assay function

Clinical Chemistry

Volumn 55, Issue 3, 2009, Pages 439-444

  Midgley, John E M ^a,b   Christofides, Nic D ^b  

^a North Lakes Clinical   (United Kingdom)

^b North Lakes Clinical Ben Rhydding Ilkley ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBODY; PLASMA PROTEIN; PREALBUMIN; THYROXINE; THYROXINE BINDING GLOBULIN;

CALIBRATION; EQUILIBRIUM DIALYSIS; EXPERIMENT; IMMUNOASSAY; MANOMETER; REVIEW; SAMPLING; ULTRAFILTRATION; ARTICLE; CLINICAL CHEMISTRY; HUMAN; ILLEGITIMACY; MEDICAL TECHNOLOGY; METHODOLOGY; REPRODUCIBILITY; STANDARD;

CLINICAL CHEMISTRY TESTS; HUMANS; ILLEGITIMACY; REPRODUCIBILITY OF RESULTS; TECHNOLOGY, MEDICAL;

EID: 62149130455     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.116525     Document Type: Review

References (74)

1. Hillgartner FB, Salati LM, Goodridge AG. Physio- logical and molecular mechanisms involved in nutritional regulation of fatty acid synthesis. Physiol Rev 1995;75:47-76.
2. Semenkovich CF. Regulation of fatty acid syn- thase (FAS). Prog Lipid Res 1995;36:43-53.
3. Witkowski A, Joshi AK, Smith S. Coupling of the de novo fatty acid biosynthesis and lipoylation pathways in mammalian mitochondria. J Biol Chem 2007;282:14178-85.
4. Wang Y, Kuhajda FP, Li JN, Pizer ES, Han WF, Sokoll LJ, Chan DW. Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patients. Can- cer Lett 2001;167:99-104.
5. Wang YY, Kuhajda FP, Cheng P, Chee WY, Li T, Helzlsouer KJ, et al. A new model ELISA, based on two monoclonal antibodies, for quantification of fatty acid synthase. J Immunoassay Immunochem 2002;23:279-92.
6. Wang YY, Kuhajda FP, Li J, Finch TT, Cheng P, Koh C, et al. Fatty acid synthase as a tumor marker: its extracellular expression in human breast cancer. J Exp Therap Oncol 2004;4:101-10.
7. Smith S, Witkowski A, Joshi AK. Structural and functional organization of the animal fatty acid synthase. Prog. Lipid Res 2003;42:289-317.
8. Schneider R, Brors B, Burger F, Camrath S, Weiss H. Two genes of the putative mitochondrial fatty acid synthase in the genome of Saccharomyces cerevisiae. Curr Genet 1997;32:384-8.
9. Miinalainen IJ, Chen ZJ, Torkko JM, Pirilä PL, Sormunen RT, Bergmann U, et al. Characteriza- tion of 2-enoyl thioester reductase from mammals: an ortholog of YBR026p/MRF1pof the yeast mitochondrial fatty acid synthesis type II. J Biol Chem 2003;278:20154-61.
10. Ronnett GV, Kleman AM, Kim EK, Landree LE, Tu Y. Fatty acid metabolism, the central nervous system, and feeding. Obesity (Silver Spring) 2006;14 Suppl 5:201S-7S.
11. López M, Lelliott CJ, Vidal-Puig A. Hypothalamic fatty acid metabolism: a housekeeping pathway that regulates food intake. Bioessays 2007;29: 248-61.
12. López M, Tovar S, Vázquez MJ, Williams LM, Diéguez C. Peripheral tissue-brain interactions in the regulation of food intake. Proc Nutr Soc 2007; 66:131-55.
13. López M, Vidal-Puig A. Brain lipogenesis and regulation of energy metabolism. Curr Opin Clin Nutr Metab Care 2008;11:483-90.
14. Wakil S. Fatty acid synthase, a proficient multi- functional enzyme. Biochem 1989;28:4523-30.
15. Witkowski A, Rangan VS, Randhawa ZI, Amy CM, Smith S. Structural organization of the multifunc- tional animal fatty acid synthase. Eur J Biochem 1991;198:571-9.
16. Smith S. The animal fatty acid synthase: one gene, one polypeptide, seven enzymes. FASEB J 1994;8:1248-59.
17. Chirala SS, Wakil SJ. Structure and function of animal fatty acid synthase. Lipids 2004;39: 1045-53.
18. Witkowski A, Joshi AK, Rangan VS, Falick AM, Witkowska HE, Smith S. Dibromopropanone cross-linking of the phosphopantetheine and ac- tive-site cysteine thiols of the animal fatty acid synthase can occur both inter- and intrasubunit: reevaluation of the side-by-side, antiparallel sub- unit model. J Biol Chem 1999;274:11557-63.
19. Asturias FJ, Chadick JZ, Cheung IK, Stark H, Wit- kowski A, Joshi AK, Smith S. Structure and mo- lecular organization of mammalian fatty acid synthase. Nat Struct Mol Biol 2005;12:225-32.
20. Maier T, Jenni S, Ban N. Architecture of mamma- lian fatty acid synthase at 4.5 Å resolution. Sci- ence (Wash DC) 2006;311:1258-62.
21. Maier T, Leibundgut M, Ban N. The crystal struc- ture of a mammalian fatty acid synthase. Science (Wash DC) 2008;32:1315-22.
22. Smith JL, Sherman DH. Biochemistry: an enzyme assembly line. Science (Wash DC) 2008;321: 1304-5.
23. Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 2008;118:829-38.
24. Chirala SS, Chang H, Matzuk M, Abu-Elheiga L, Mao J, Mahon K, et al. Fatty acid synthesis is essential in embryonic development: fatty acid synthase null mutants and most of the heterozy- gotes die in utero. Proc Natl Acad Sci USA 2003; 100:6358-63.
25. Chakravarthy MV, Pan Z, Zhu Y, Tordjman K, Schneider JG, Coleman T, et al. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab 2005;1:309-22.
26. Hellerstein MK, Schwarz JM, Neese RA. Regula- tion of hepatic de novo lipogenesis in humans. Annu Rev Nutr 1996;16:523-57.
27. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessu- run J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005;115:1343-51.
28. Hudgins LC, Hellerstein M, Seidman C, Neese R, Diakun J, Hirsch J. Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohy- drate diet. J Clin Invest 97:2081-91.
29. Hudgins LC, Hellerstein MK, Seidman CE, Neese RA, Tremaroli JD, Hirsch J. Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects. J Lipid Res 2000;41:595-604.
30. Morral N, Edenberg HJ, Witting SR, Altomonte J, Chu T, Brown M. Effects of glucose metabolism on the regulation of genes of fatty acid synthesis and triglyceride secretion in the liver. J Lipid Res 2007;48:1499-510.
31. Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM, et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 2008;48:993-9.
32. Blüher M, Patti ME, Gesta S, Kahn BB, Kahn CR. Intrinsic heterogeneity in adipose tissue of fat- specific insulin receptor knock-out mice is asso- ciated with differences in patterns of gene ex- pression. J Biol Chem 2004;279:31891-901.
33. Richardson DK, Czech MP. Diminished activities of fatty acid synthesis enzymes in insulin-resis- tant adipocytes from spontaneously obese rats. Horm Metab Res 1979;11:427-31.
34. Letexier D, Pinteur C, Large V, Frering V, Beylot M. Comparison of the expression and activity of the lipogenic pathway in human and rat adipose tissue. J Lipid Res 2003;44:2127-34.
35. Marin P, Hogh-Kristiansen I, Jansson S, Krot- kiewski M, Holm G, Bjorntorp P. Uptake of glu- cose carbon in muscle glycogen and adipose tis- sue triglycerides in vivo in humans. Am J Physiol 1992;263:E473-E480.
36. Swierczynski J, Goyke E, Wach L, Pankiewicz A, Kochan Z, Adamonis W, et al. Comparative study of the lipogenic potential of human and rat adi- pose tissue. Metabolism 2000;49:594-9.
37. Aarsland A, Chinkes D, Wolfe RR. Hepatic and whole-body fat synthesis in humans during car- bohydrate overfeeding. Am J Clin Nutr 1997;65: 1774-82.
38. Chascione C, Elwyn DH, Davila M, Gil KM, Aska- nazi J, Kinney JM. Effect of carbohydrate intake on de novo lipogenesis in human adipose tissue. Am J Physiol 1987;253:E664-E669.
39. Guichard C, Dugail I, Le Liepvre X, Lavau M. Genetic regulation of fatty acid synthetase ex- pression in adipose tissue: overtranscription of the gene in genetically obese rats. J Lipid Res 1992;33:679-87.
40. Wang Y, Jones Voy B, Urs S, Kim S, Soltani- Bejnood M, Quigley N, et al. The human fatty acid synthase gene and de novo lipogenesis are coordinately regulated in human adipose tissue. J Nutr 2004;134:1032-8.
41. Berndt J, Kovacs P, Ruschke K, Klöting N, Fasshauer M, Schön MR, et al. Fatty acid syn- thase gene expression in human adipose tissue: association with obesity and type 2 diabetes. Diabetologia 2007;50:1472-80.
42. Liu LH, Wang XK, Hu YD, Kang JL, Wang LL, Lin S. Effects of a fatty acid synthase inhibitor on adipocyte differentiation of mouse 3T3-L1 cells. Acta Pharmacol Sin 2004;25:1052-7.
43. Kolehmainen M, Vidal H, Alhava E, Uusitupa MIJ. Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity. Obes Res 2001;9:706-12.
44. Diraison F, Dusserre E, Vidal H, Sothier M, Beylot M. Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity. Am J Physiol Endocrinol Metab 2002;282:E46-51.
45. Minehira K, Vega N, Vidal H, Acheson K, Tappy L. Effect of carbohydrate overfeeding on whole body macronutrient metabolism and expression of lipogenic enzymes in adipose tissue of lean and overweight humans. Int J Obes Relat Metab Disord 2004;28:1291-8.
46. Nadler, S, Stoehr J, Schueler K, Tanimoto G, Yandell B, Attie A. The expression of adipogenic genes is decreased in obesity and diabetes mel- litus. Proc Natl Acad Sci USA 2000;97:11371-5.
47. Soukas A, Cohen P, Socci N, Friedman J. Leptin specific patterns of gene expression in white ad- ipose tissue. Genes Dev 2000;14:963-80.
48. Moustaid N, Jones B, Taylor J. Insulin increases lipogenic enzyme activity in human adipocytes in primary cultures. J Nutr 1996;126:965-70.
49. Claycombe KJ, Jones BH, Standridge MK, Guo Y, Chun JT, Taylor JW, Moustad-Moussa N. Insulin increases fatty acid synthase gene transcription in human adipocytes. Am J Physiol 1998;274: R1253-59.
50. Bai, Y, Zhang S, Kim K, Lee J, Kim R. Obese gene expression alters the ability of 30A5 preadipo- cytes to respond to lipogenic hormones. J Biol Chem 1996;271:13939-42.
51. Kern, P, Saghisadeh M, Ong J, Bosch R, Deem R, Simsolo R. The expression of tumor necrosis fac- tor in human adipose tissue. Regulation by obe- sity, weight loss and relationship to lipoprotein lipase. J Clin Invest 1995;1995;95:2111-9.
52. Doerrler W, Feingold K, Grunfeld C. Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. Cytokine 1994;1994;5: 478-84.
53. Hudgins LC, Baday A, Hellerstein MK, Parker TS, Levine DM, Seidman CE, et al. The effect of dietary carbohydrate on genes for fatty acid syn- thase and inflammatory cytokines in adipose tis- sues from lean and obese subjects. J Nutr Bio- chem 2008;19:237-45.
54. Diraison F, Yankah V, Letexier D, Dusserre E, Jones P, Beylot M. Differences in the regulation of 438 Clinical Chemistry 55:3 (2009) adipose tissue and liver lipogenesis by carbohy- drates in humans. J Lipid Res 2003;44:846-53.
55. Letexier D, Pinteur C, Large V, Frering V, Beylot M. Comparison of the expression and activity of the lipogenic pathway in human and rat adipose tissue. J Lipid Res 2003;44:2127-34.
56. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004;4: 891-9.
57. Lupu R, Menendez JA. Targeting fatty acid syn- thase in breast and endometrial cancer: An alter- native to selective estrogen receptor modulators? Endocrinology 2006;147:4056-66.
58. Menendez JA, Lupu R. Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells. Curr Opin Clin Nutr Metab Care 2006;9:346-57.
59. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007;7:763-77.
60. Calle EE, Kaaks R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-91.
61. Kovacs P, Harper I, Hanson RL, Infante AM, Bo- gardus C, Tataranni PA, Baier LJ. A novel mis- sense substitution (Val1483Ile) in the fatty acid synthase gene (FAS) is associated with percent- age of body fat and substrate oxidation rates in nondiabetic Pima Indians. Diabetes 2004;53: 1915-9.
62. Körner A, Ma L, Franks PW, Kiess W, Baier LJ, Stumvoll M, Kovacs P. Sex-specific effect of the Val1483Ile polymorphism in the fatty acid syn- thase gene (FAS) on body mass index and lipid profile in Caucasian children. Int J Obes (Lond) 2007;31:353-8.
63. Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 2002;20: 42-51.
64. Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD. Metformin and reduced risk of cancer in diabetic patients. BMJ 2005;330: 1304-5.
65. Bowker SL, Majumdar SR, Veugelers P, Johnson JA. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 2006;29:254-8.
66. Zakikhani M, Dowling R, Fantus IG, Sonenberg N, Pollak M. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res 2006;66:10269-73.
67. Dowling RJ, Zakikhani M, Fantus IG, Pollak M, Sonenberg N. Metformin inhibits mammalian tar- get of rapamycin-dependent translation initiation in breast cancer cells. Cancer Res 2007;67: 10804-12.
68. Algire C, Zakikhani M, Blouin MJ, Shuai JH, Pollak M. Metformin attenuates the stimulatory effect of a high energy diet on in vivo h59 carcinoma growth. Endocr Relat Cancer 2008;15:833-9.
69. Viollet B, Mounier R, Leclerc J, Yazigi A, Foretz M, Andreelli F. Targeting AMP-activated protein ki- nase as a novel therapeutic approach for the treatment of metabolic disorders. Diabetes Metab 2007;33:395-402.
70. Goodwin PJ, Pritchard KI, Fantus IG, et al. Met- formin lowers fasting insulin levels in hyperinsu- linemia early stage breast cancer patients: results of a phase II study. Breast Cancer Res Treat 2006;100:S109.
71. Harrington M, Pond-Tor S, Boney CM. Role of epidermal growth factor and ErbB2 receptors in 3T3-L1 adipogenesis. Obesity (Silver Spring) 2007;15:563-71.
72. Pagano E, Coso O, Calvo JC. Down-modulation of erbB2 activity is necessary but not enough in the differentiation of 3T3-L1 preadipocytes. J Cell Biochem 2008;104:274-85.
73. Vazquez-Martin A, Moreno A, Colomer R, Me- nendez JA, Ropero S, Oliveras C, Palacios J. Mi- croarray gene expression analysis of fatty acid synthase (FAS) signaling on breast cancer cell lines [Abstract]. J Clin Oncol 2004;22:9690.
74. Schmid B, Rippmann JF, Tadayyon M, Hamilton BS. Inhibition of fatty acid synthase prevents preadipocyte differentiation. Biochem Biophys Res Commun 2005;328:1073-82.